Increased expression of MDM2, cyclin D1, and p27 Kip1 in carcinogen‐induced rat mammary tumors
It is thought that environmental pollutants, such as polycyclic aromatic hydrocarbons (PAH), contribute to human breast tumorigenesis, yet their roles remain incompletely elucidated. The prototypical PAH 7,12‐dimethylbenz(α)anthracene (DMBA) specifically and effectively induces mammary tumor formati...
Gespeichert in:
Veröffentlicht in: | Journal of cellular biochemistry 2005-08, Vol.95 (5), p.875-884 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | It is thought that environmental pollutants, such as polycyclic aromatic hydrocarbons (PAH), contribute to human breast tumorigenesis, yet their roles remain incompletely elucidated. The prototypical PAH 7,12‐dimethylbenz(α)anthracene (DMBA) specifically and effectively induces mammary tumor formation in rodent models. In an attempt to explore the molecular mechanisms by which PAH initiates and promotes mammary tumorigenesis, we examined the expression of several cell cycle regulators in rat mammary tumors induced by DMBA. Expression of cyclin D1, murine double minute‐2 (MDM2), and Akt was up‐regulated in tumors in comparison to normal mammary glands, as indicated by RT‐PCR, Western blot analysis, and immunohistochemical staining. Expression of p27
Kip1
protein was also elevated in the tumors with increased cytoplasmic localization. However, RB protein remained hyperphosphorylated. To directly test the effects of DMBA, the MCF‐7 human breast cancer cells were treated. DMBA induced MDM2 expression in a dose‐ and time‐dependent fashion in the MCF‐7 cells, and this activation appeared to be p53 dependent. These data suggest that activation of cyclin D1, MDM2, and AKT as well as increased expression and cytoplasmic localization of p27
Kip1
may play a role in this model of environmental pollutant‐induced mammary tumorigenesis. © 2005 Wiley‐Liss, Inc. |
---|---|
ISSN: | 0730-2312 1097-4644 |
DOI: | 10.1002/jcb.20414 |